Mono Pharmacare Limited — Important, 20-01-2025: Updates

The company has communicated that it is not required to submit the Corporate Governance Report for the quarter ended December 31, 2024, based on the exemptions available for entities listed on the SME exchange. This update indicates compliance with SEBI regulations and streamlines the reporting process for the company. While the immediate impact may be limited, it highlights the company's adherence to regulatory requirements, potentially reducing administrative burdens. Investors should note this as part of the company’s governance strategy, reflecting a focus on operational efficiency.